Our data demonstrate that anti-PD1 therapy expands these Ccl5-expressing dysfunctional CD8 T cells (CD8Ex1) (Fig. 4E) within the lungs of tumor-burdened mice, potentially limiting the effectiveness of anti-PD1 therapies. Here, CCL5 is linked to neoplasm.